Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPEREIRA, Andreia Vieira
dc.contributor.authorBARROS, Gustavo de
dc.contributor.authorPINTO, Erika Gracielle
dc.contributor.authorTEMPONE, Andre Gustavo
dc.contributor.authorORSI, Ricardo de Oliveira
dc.contributor.authorSANTOS, Lucilene Delazari dos
dc.contributor.authorCALVI, Sueli
dc.contributor.authorFERREIRA JR., Rui Seabra
dc.contributor.authorPIMENTA, Daniel Carvalho
dc.contributor.authorBARRAVIERA, Benedito
dc.date.accessioned2016-03-14T14:51:02Z
dc.date.available2016-03-14T14:51:02Z
dc.date.issued2016
dc.description.abstractBackground: Apis mellifera venom, which has already been recommended as an alternative anti-inflammatory treatment, may be also considered an important source of candidate molecules for biotechnological and biomedical uses, such as the treatment of parasitic diseases. Methods: Africanized honeybee venom from Apis mellifera was fractionated by RP-C18-HPLC and the obtained melittin was incubated with promastigotes and intracellular amastigotes of Leishmania (L.) infantum. Cytotoxicity to mice peritoneal macrophages was evaluated through mitochondrial oxidative activity. The production of anti-and pro-inflammatory cytokines, NO and H2O2 by macrophages was determined. Results: Promastigotes and intracellular amastigotes were susceptible to melittin (IC50 28.3 mu g.mL(-1) and 1.4 mu g.mL(-1), respectively), but also showed mammalian cell cytotoxicity with an IC50 value of 5.7 mu g.mL(-1). Uninfected macrophages treated with melittin increased the production of IL-10, TNF-alpha, NO and H2O2. Infected melittin-treated macrophages increased IL-12 production, but decreased the levels of IL-10, TNF-alpha, NO and H2O2. Conclusions: The results showed that melittin acts in vitro against promastigotes and intracellular amastigotes of Leishmania (L.) infantum. Furthermore, they can act indirectly on intracellular amastigotes through a macrophage immunomodulatory effect.
dc.description.indexPubMed
dc.identifier.citationJOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, v.22, article ID 1, 8p, 2016
dc.identifier.doi10.1186/s40409-016-0055-x
dc.identifier.issn1678-9199
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/13635
dc.language.isoeng
dc.publisherBIOMED CENTRAL LTD
dc.relation.ispartofJournal of Venomous Animals and Toxins Including Tropical Diseases
dc.rightsopenAccess
dc.rights.holderCopyright BIOMED CENTRAL LTD
dc.subjectMelittin
dc.subjectApis mellifera
dc.subjectLeishmania
dc.subjectLeishmaniasis
dc.subjectPeptides
dc.subjectToxins
dc.subjectAntiparasitic
dc.subjectCytokines
dc.subject.otherapis-mellifera venom
dc.subject.otherantimicrobial peptides
dc.subject.othernitric-oxide
dc.subject.otherphospholipase a(2)
dc.subject.othertrypanosoma-cruzi
dc.subject.otherhybrid peptide
dc.subject.otherbee venom
dc.subject.otherchagasi
dc.subject.othermacrophages
dc.subject.othersuperoxide
dc.subject.wosToxicology
dc.subject.wosTropical Medicine
dc.subject.wosZoology
dc.titleMelittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalPEREIRA, Andreia Vieira:Sao Paulo State Univ UNESP Univ Estadual Paulista, Botucatu Med Sch, Grad Program Trop Dis, BR-18610307 Botucatu, SP, Brazil
hcfmusp.author.externalBARROS, Gustavo de:Sao Paulo State Univ UNESP Univ Estadual Paulista, Botucatu Med Sch, Grad Program Trop Dis, BR-18610307 Botucatu, SP, Brazil
hcfmusp.author.externalTEMPONE, Andre Gustavo:Adolfo Lutz Inst, Dept Parasitol, Sao Paulo, SP, Brazil
hcfmusp.author.externalORSI, Ricardo de Oliveira:Sao Paulo State Univ UNESP Univ Estadual Paulista, Dept Anim Prod, Sch Vet Med & Anim Husb, BR-18610307 Botucatu, SP, Brazil; Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
hcfmusp.author.externalSANTOS, Lucilene Delazari dos:Sao Paulo State Univ UNESP Univ Estadual Paulista, Botucatu Med Sch, Grad Program Trop Dis, BR-18610307 Botucatu, SP, Brazil; Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
hcfmusp.author.externalCALVI, Sueli:Sao Paulo State Univ UNESP Univ Estadual Paulista, Botucatu Med Sch, Grad Program Trop Dis, BR-18610307 Botucatu, SP, Brazil; Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
hcfmusp.author.externalFERREIRA JR., Rui Seabra:Sao Paulo State Univ UNESP Univ Estadual Paulista, Botucatu Med Sch, Grad Program Trop Dis, BR-18610307 Botucatu, SP, Brazil; Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
hcfmusp.author.externalPIMENTA, Daniel Carvalho:Butantan Inst, Lab Biochem & Biophys, Sao Paulo, SP, Brazil
hcfmusp.author.externalBARRAVIERA, Benedito:Sao Paulo State Univ UNESP Univ Estadual Paulista, Botucatu Med Sch, Grad Program Trop Dis, BR-18610307 Botucatu, SP, Brazil; Sao Paulo State Univ UNESP Univ Estadual Paulista, Ctr Study Venoms & Venomous Anim CEVAP, BR-18610307 Botucatu, SP, Brazil
hcfmusp.citation.scopus24
hcfmusp.contributor.author-fmusphcERIKA GRACIELLE PINTO
hcfmusp.description.articlenumber1
hcfmusp.description.volume22
hcfmusp.origemWOS
hcfmusp.origem.pubmed26752985
hcfmusp.origem.scieloSCIELO:S1678-91992016000100301
hcfmusp.origem.scopus2-s2.0-84953405951
hcfmusp.origem.wosWOS:000367782800001
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceAlvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
hcfmusp.relation.referenceAlberola J, 2004, ANTIMICROB AGENTS CH, V48, P641, DOI 10.1128/AAC.48.2.641-643.2004
hcfmusp.relation.referenceHernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x
hcfmusp.relation.referenceCezario GAG, 2011, MEM I OSWALDO CRUZ, V106, P573, DOI 10.1590/S0074-02762011000500010
hcfmusp.relation.referenceTripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x
hcfmusp.relation.referenceAdade CM, 2012, PARASITOLOGY, V139, P1444, DOI 10.1017/S0031182012000790
hcfmusp.relation.referenceKwon YB, 2001, ACUPUNCTURE ELECTRO, V26, P59
hcfmusp.relation.referenceSciani JM, 2010, PEPTIDES, V31, P1473, DOI 10.1016/j.peptides.2010.05.001
hcfmusp.relation.referencePetricevich VL, 2000, TOXICON, V38, P1253, DOI 10.1016/S0041-0101(99)00227-5
hcfmusp.relation.referenceMukbel RM, 2007, AM J TROP MED HYG, V76, P669
hcfmusp.relation.referenceBradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287
hcfmusp.relation.referenceReimao JQ, 2011, EXP PARASITOL, V128, P111, DOI 10.1016/j.exppara.2011.02.021
hcfmusp.relation.referenceGERZER R, 1988, THROMB RES, V52, P11, DOI 10.1002/cber.187901201117
hcfmusp.relation.referenceBelkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497
hcfmusp.relation.referenceda Costa-Silva TA, 2015, J NAT PROD, V78, P653, DOI 10.1021/np500809a
hcfmusp.relation.referenceRobak T, 1998, EUR CYTOKINE NETW, V9, P145
hcfmusp.relation.referenceJacobs T, 2003, ANTIMICROB AGENTS CH, V47, P607, DOI 10.1128/AAC.47.2.607-613.2003
hcfmusp.relation.referenceKulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200
hcfmusp.relation.referenceAnsari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017
hcfmusp.relation.referenceTempone AG, 2008, TOXICON, V52, P13, DOI 10.1016/j.toxicon.2008.05.008
hcfmusp.relation.referenceFerre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]
hcfmusp.relation.referencePICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3
hcfmusp.relation.referenceMoon DO, 2007, INT IMMUNOPHARMACOL, V7, P1092, DOI 10.1016/j.intimp.2007.04.005
hcfmusp.relation.referenceKlocek G, 2008, BIOCHEMISTRY-US, V47, P2841, DOI 10.1021/bi702258z
hcfmusp.relation.referenceStromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070
hcfmusp.relation.referenceDiaz-Achirica P, 1998, BIOCHEM J, V330, P453
hcfmusp.relation.referenceWatford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x
hcfmusp.relation.referencePassero LFD, 2008, PARASITOL RES, V102, P1025, DOI 10.1007/s00436-007-0871-6
hcfmusp.relation.referenceMaher S, 2006, BIOCHEM PHARMACOL, V71, P1289, DOI 10.1016/j.bcp.2006.01.012
hcfmusp.relation.referenceSantos LD, 2011, J VENOM ANIM TOXINS, V17, P364, DOI 10.1590/S1678-91992011000400003
hcfmusp.relation.referencePerez-Santos JLM, 2001, PARASITE IMMUNOL, V23, P599, DOI 10.1046/j.1365-3024.2001.00421.x
hcfmusp.relation.referenceAllahverdiyev AM, 2013, EXP PARASITOL, V135, P55, DOI 10.1016/j.exppara.2013.06.001
hcfmusp.relation.referenceBechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
hcfmusp.relation.referenceFerreira ASSBS, 2013, TOXICON, V69, P50, DOI 10.1016/j.toxicon.2013.01.003
hcfmusp.relation.referenceBarros GAC, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0049-0
hcfmusp.relation.referenceBogdan C, 2000, NITRIC OXIDE, P443
hcfmusp.relation.referenceCarter V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003790
hcfmusp.relation.referenceChen L. C., 2010, J NANOMATER, V2010, P1
hcfmusp.relation.referenceCoelho-Castelo AAM, 2009, MEDICINA RIBEIRAO PR, V42, P127
hcfmusp.relation.referenceConlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004
hcfmusp.relation.referenceCota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665
hcfmusp.relation.referenceCummings HE, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/294389
hcfmusp.relation.referenceFerreira RS, 2010, TOXICON, V56, P355, DOI 10.1016/j.toxicon.2010.03.023
hcfmusp.relation.referenceLapara NJ, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-8
hcfmusp.relation.referenceMarques Nuno, 2007, Acta Med Port, V20, P291
hcfmusp.relation.referencePICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1
hcfmusp.relation.referenceSundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850
hcfmusp.relation.referenceTADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3
hcfmusp.relation.referenceVerma S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010107
hcfmusp.relation.referenceZar J. H., 2010, BIOSTAT ANAL, P944
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication4b133b6d-859e-4fa8-9990-44df1e491ff3
relation.isAuthorOfPublication.latestForDiscovery4b133b6d-859e-4fa8-9990-44df1e491ff3
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_PEREIRA_Melittin_induces_in_vitro_death_of_Leishmania_Leishmania_2016.PDF
Tamanho:
798.14 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)